Groupe Gorgé and the German and American shareholders of DeltaMed have agreed the acquisition by Groupe Gorgé of 100% of the capital of DeltaMed GmbH. DeltaMed mainly develops photosensitive resins. The company was acquired directly by Groupe Gorgé through a subsidiary formed for the purpose, which will eventually bring together all the group's 3D printing activities, starting with Prodways.
A leading player in 3D printing materials
DeltaMed has been developing photosensitive products for medical and industrial uses, especially in the dental and hearing aid sectors, for over fifteen years. DeltaMed has particular expertise in the field of development of photosensitive resins for additive manufacturing applications.
The company currently supplies resins to several leading manufacturers of 3D printing machines, providing development, certification and production services. DeltaMed can call on:
- recognized R&D teams which have developed four ranges of resins with different features for 3D printing (hearing aid, dental, casting, technical), used in a total of 30 different products;
- a quality management system to fulfil all necessary requirements to market medical devices in the European Union, the United States of America, Canada and other countries ;
- a production process designed for manufacturing products in compliance with the most stringent standards. It is not yet running at full capacity and can produce up to 50 tons of resin per year.
A major step in the Group's development plan for 3D printing
Through its subsidiary Prodways, Gorgé Group today has the most efficient 3D printing machines for a certain number of applications. However, the supply of materials was too limited to offer each customer the specific machine-material combination that best suited each application. This strategic acquisition will largely meet this need.
Vertical integration, up to the production of specific resins internally, makes it possible to master and capture the whole of the value created by the machine-material combination for the applications developed by the Group.
Looking beyond the Group's own needs, DeltaMed will continue to supply resins to other companies in the industry with the aim of strengthening its position as a leading player in this high-potential field.Information réglementée
Communiqués au titre de l'obligation d'information permanente :
- Activité de l'émetteur (acquisitions, cessions...) Communiqué intégral et original au format PDF :
|GROUPE GORGE||Euronext Paris||24.19 (c)||0.83%||15 854|